VivoSeq
Oncology

Solid Tumors, Adult

1

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Solid Tumors, Adult is an early-stage landscape with 1 program across 1 company. The most active players are HighField Biopharmaceuticals Corporation.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

H

HighField Biopharmaceuticals Corporation

3 programs

Phase 1

Pipeline

Programs by Phase

Preclinical1

HMPL-A251

Hutchmed

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

2

clinical trials

Recruiting2 · 100%

Clinical Trials

Trial Activity

A Phase Ⅰ/Ⅱa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HMPL-A251 in Participants With Advanced or Metastatic HER2-Expressing Solid Tumors
Recruiting·HHutchmed·Preclinical·NCT07228247·147 enrolled
A Phase 1 Clinical Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of HF158K1 in Participants With HER-2 Expressing Advanced Solid Tumors
Recruiting·HHighField Biopharmaceuticals Corporation·Phase 1·NCT05861895·84 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)